Correlation Between Pfizer and Shuttle Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Pfizer and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Shuttle Pharmaceuticals.

Diversification Opportunities for Pfizer and Shuttle Pharmaceuticals

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Pfizer and Shuttle is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Pfizer i.e., Pfizer and Shuttle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pfizer and Shuttle Pharmaceuticals

Considering the 90-day investment horizon Pfizer is expected to generate 2.82 times less return on investment than Shuttle Pharmaceuticals. But when comparing it to its historical volatility, Pfizer Inc is 1.85 times less risky than Shuttle Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  38.00  in Shuttle Pharmaceuticals on February 5, 2024 and sell it today you would earn a total of  5.00  from holding Shuttle Pharmaceuticals or generate 13.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Shuttle Pharmaceuticals

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Shuttle Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Shuttle Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Shuttle Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Shuttle Pharmaceuticals

The main advantage of trading using opposite Pfizer and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.
The idea behind Pfizer Inc and Shuttle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing